Rigel Pharmaceuticals
RIGL
#7548
Rank
ยฃ0.18 B
Marketcap
ยฃ10.43
Share price
0.44%
Change (1 day)
17.75%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ0.12 B

According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ0.12 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.11 B-6.34%
2022-12-31ยฃ0.12 B20.8%
2021-12-31ยฃ0.10 B80.93%
2020-12-31ยฃ55.92 M-20.84%
2019-12-31ยฃ70.64 M208.37%
2018-12-31ยฃ22.91 M67.69%
2017-12-31ยฃ13.66 M-27.04%
2016-12-31ยฃ18.72 M-31.18%
2015-12-31ยฃ27.21 M63.62%
2014-12-31ยฃ16.63 M54.24%
2013-12-31ยฃ10.78 M-16.76%
2012-12-31ยฃ12.95 M-3.93%
2011-12-31ยฃ13.48 M0.88%
2010-12-31ยฃ13.36 M-30.51%
2009-12-31ยฃ19.23 M-30.12%
2008-12-31ยฃ27.52 M63.55%
2007-12-31ยฃ16.83 M26.75%
2006-12-31ยฃ13.27 M-41.4%
2005-12-31ยฃ22.66 M63.9%
2004-12-31ยฃ13.82 M57.68%
2003-12-31ยฃ8.76 M-25.61%
2002-12-31ยฃ11.78 M-2.37%
2001-12-31ยฃ12.07 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ52.82 M-56.21%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ49.33 B 40,792.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ64.75 B 53,576.68%๐Ÿ‡บ๐Ÿ‡ธ USA